← Open Payments lookup

EILEEN WIDRICK: Open Payments

NPI 1083800874 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,413 in 51 payments from 14 companies in 2025. Trend: 2023 $1,452 · 2024 $2,166 · 2025 $1,413

Food & beverage: $1,413
CompanyPaymentsAmount
Lilly USA, LLC13$479
Novo Nordisk Inc15$359
Dexcom, Inc.1$134
GlaxoSmithKline, LLC.4$82
AstraZeneca Pharmaceuticals LP4$74
Takeda Pharmaceuticals U.S.A., Inc.3$54
Bayer Healthcare Pharmaceuticals Inc.2$53
ABBVIE INC.2$44
Phathom Pharmaceuticals, Inc.2$36
CSL Behring1$24

Products named: Ozempic, ZEPBOUND, KISUNLA, DEXCOM G7 GSS (161), Wegovy, TRELEGY ELLIPTA, JARDIANCE, TRINTELLIX.

Industry payments across TX — which companies pay providers there.